Long-term duration of protection of ancestral-strain monovalent vaccines and effectiveness of the bivalent BA.1 boosters against COVID-19 hospitalisation during a period of BA.5, BQ.1, CH.1.1. and XBB.1.5 circulation in England
View ORCID ProfileFreja Cordelia Møller Kirsebom, Nick Andrews, Julia Stowe, Mary Ramsay, Jamie Lopez Bernal
doi: https://doi.org/10.1101/2023.03.31.23288018
Freja Cordelia Møller Kirsebom
1UK Health Security Agency, London, United Kingdom
PhDNick Andrews
1UK Health Security Agency, London, United Kingdom
2NIHR Health Protection Research Unit in Vaccines and Immunisation, London School of Hygiene and Tropical Medicine, London, United Kingdom
PhDJulia Stowe
1UK Health Security Agency, London, United Kingdom
PhDMary Ramsay
1UK Health Security Agency, London, United Kingdom
2NIHR Health Protection Research Unit in Vaccines and Immunisation, London School of Hygiene and Tropical Medicine, London, United Kingdom
MBBS, FFPHJamie Lopez Bernal
1UK Health Security Agency, London, United Kingdom
2NIHR Health Protection Research Unit in Vaccines and Immunisation, London School of Hygiene and Tropical Medicine, London, United Kingdom
3NIHR Health Protection Research Unit in Respiratory Infections, Imperial College London, United Kingdom
PhD, MBBSData Availability
All data produced in the present work are contained in the manuscript.
Posted March 31, 2023.
Long-term duration of protection of ancestral-strain monovalent vaccines and effectiveness of the bivalent BA.1 boosters against COVID-19 hospitalisation during a period of BA.5, BQ.1, CH.1.1. and XBB.1.5 circulation in England
Freja Cordelia Møller Kirsebom, Nick Andrews, Julia Stowe, Mary Ramsay, Jamie Lopez Bernal
medRxiv 2023.03.31.23288018; doi: https://doi.org/10.1101/2023.03.31.23288018
Long-term duration of protection of ancestral-strain monovalent vaccines and effectiveness of the bivalent BA.1 boosters against COVID-19 hospitalisation during a period of BA.5, BQ.1, CH.1.1. and XBB.1.5 circulation in England
Freja Cordelia Møller Kirsebom, Nick Andrews, Julia Stowe, Mary Ramsay, Jamie Lopez Bernal
medRxiv 2023.03.31.23288018; doi: https://doi.org/10.1101/2023.03.31.23288018
Subject Area
Subject Areas
- Addiction Medicine (372)
- Allergy and Immunology (690)
- Anesthesia (184)
- Cardiovascular Medicine (2755)
- Dermatology (235)
- Emergency Medicine (414)
- Epidemiology (12403)
- Forensic Medicine (10)
- Gastroenterology (784)
- Genetic and Genomic Medicine (4263)
- Geriatric Medicine (396)
- Health Economics (699)
- Health Informatics (2758)
- Health Policy (1020)
- Hematology (370)
- HIV/AIDS (880)
- Medical Education (404)
- Medical Ethics (112)
- Nephrology (454)
- Neurology (4043)
- Nursing (216)
- Nutrition (600)
- Oncology (2129)
- Ophthalmology (604)
- Orthopedics (251)
- Otolaryngology (313)
- Pain Medicine (256)
- Palliative Medicine (77)
- Pathology (478)
- Pediatrics (1149)
- Primary Care Research (470)
- Public and Global Health (6653)
- Radiology and Imaging (1446)
- Respiratory Medicine (886)
- Rheumatology (421)
- Sports Medicine (353)
- Surgery (464)
- Toxicology (57)
- Transplantation (192)
- Urology (171)